Vmbook Online ordering

Electromed Inc

Electromed, Inc. (ELMD) is a medical device manufacturer based in New Prague, Minnesota, United States. The company specializes in the design, development, manufacturing, and marketing of airway clearance therapies for patients with respiratory conditions. Its primary product, the SmartVest® Airway Clearance System, is a vest that uses high-frequency chest wall oscillation (HFCWO) to help patients clear their airways and improve their respiratory function.

Electromed has been a publicly traded company since 1989 and is listed on the OTCQB Venture Market under the ticker symbol "ELMD."

Here is some general information about Electromed, Inc.:

1. Market Capitalization: As of February 23, 2023, Electromed's market capitalization is approximately $21.5 million.

2. Earnings: In the third quarter of 2022, Electromed reported net income of $287,000 or $0.07 per diluted share, compared to a net loss of $501,000 or $0.13 per diluted share in the same period of 2021.

3. Revenue: In the third quarter of 2022, Electromed reported net sales of $3.1 million, an increase of 11% compared to the same period of 2021.

4. Growth: Electromed's revenue has been growing steadily in recent years, driven by increasing demand for its SmartVest® Airway Clearance System. In the past five years, Electromed's revenue has grown at a compound annual growth rate (CAGR) of 8.6%.

5. Dividends: Electromed does not currently pay a dividend.

Investors interested in Electromed, Inc. should perform their own due diligence and consult with a financial advisor before making any investment decisions. It's important to keep in mind that investing in individual stocks carries significant risks, and investors should only invest money they can afford to lose.

Sources:

* Electromed, Inc. Investor Relations website

* Yahoo Finance

* MarketWatch

* Finviz

* Zacks Investment Research